Related Experiment Video
Updated: Aug 28, 2025

09:43
Isolation, Culture, and Characterization of Prostate Cancer-Associated Fibroblasts
Published on: August 1, 2025
146
The Roles of Tumor-Associated Macrophages in Prostate Cancer
Chenglin Han1, Yuxuan Deng1, Wenchao Xu1
1Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Journal of Oncology
|September 19, 2022
Summary
Tumor-associated macrophages (TAMs) play a key role in prostate cancer (PCa) progression and metastasis. Targeting TAMs offers a promising therapeutic strategy to improve outcomes for prostate cancer patients.
Area of Science:
- Oncology
- Immunology
- Urology
Background:
- Prostate cancer (PCa) is a leading cause of cancer mortality in men.
- Tumor-associated macrophages (TAMs) constitute a significant portion of the tumor mass and influence PCa progression.
- M2-like TAMs in the tumor microenvironment (TME) promote malignant characteristics of PCa, from initiation to metastasis.
Purpose of the Study:
- To review the fundamental roles of TAMs in prostate adenocarcinoma.
- To explore mechanisms of macrophage recruitment and polarization in PCa.
- To discuss the clinical implications for developing TAM-targeted therapies.
Main Methods:
- Literature review of existing studies on TAMs in prostate cancer.
- Analysis of mechanisms driving macrophage recruitment and M2 polarization.
- Evaluation of clinical data correlating TAM density with PCa characteristics.
Main Results:
- TAM density is higher in PCa compared to benign prostatic hyperplasia (BPH).
- Increased TAM density correlates with poorer clinicopathological features in PCa.
- TAMs are implicated in multiple stages of PCa, including tumorigenesis and metastasis.
Conclusions:
- TAMs are a critical component of the PCa TME and a promising therapeutic target.
- Understanding TAM recruitment and polarization is key to developing effective anti-PCa strategies.
- Targeting TAMs, alone or in combination, may disrupt the PCa 'vicious cycle' and improve patient outcomes.
Related Concept Videos
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Mesenchymal Stem Cells
4.9K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.9K

